Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systematic discovery of multicomponent therapeutics.

Alexis A Borisy1, Peter J Elliott, Nicole W Hurst

  • 1CombinatoRx Incorporated, 650 Albany Street, Boston, MA 02118, USA.

Proceedings of the National Academy of Sciences of the United States of America
|June 12, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emerging roles of ferroptosis in modulating the immune landscape of glial tumours.

Nature cell biology·2026
Same author

MiR-940 Suppresses Ferroptosis by Controlling Expression of Key Regulatory Genes.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Therapeutic Patient Education for Pediatric Atopic Dermatitis Patients: A Randomized Controlled Trial.

Pediatric dermatology·2026
Same author

GPX4 regulates lipid peroxidation and ferroptosis of stored red blood cells.

Blood. Red cells & iron·2026
Same author

Dissecting Polypharmacology in Phenotypic Screening to Resolve Ferroptotic and Necrotic Cell-Death Mechanisms.

ACS medicinal chemistry letters·2026
Same author

When Pathways Converge: Iron, Lipid Peroxidation, and α-Synuclein in Ferroptosis-Driven Dopaminergic Neurodegeneration.

Journal of neurochemistry·2026

High-throughput screening identifies novel drug combinations. This method reveals synergistic effects, like fungicidal activity against resistant Candida albicans and tumor growth inhibition in mice, offering new therapeutic strategies.

Area of Science:

  • Pharmacology
  • Drug Discovery
  • Systems Biology

Background:

  • Multicomponent therapies are established in medicine for various diseases.
  • Developing effective drug combinations requires efficient screening methods.

Purpose of the Study:

  • To develop and apply a high-throughput screening method for identifying effective therapeutic compound combinations.
  • To uncover unexpected interactions between small molecules and their underlying biological pathways.

Main Methods:

  • Systematic screening of approximately 120,000 two-component combinations of reference-listed drugs.
  • Utilizing a high-throughput screening approach to identify synergistic drug interactions.

Main Results:

  • Identified a fungistatic and analgesic combination with fungicidal activity against drug-resistant Candida albicans without affecting human cells.

Related Experiment Videos

  • Discovered that glucocorticoid and antiplatelet agents synergistically suppress tumor necrosis factor-alpha production.
  • Found that a combination of antipsychotic and antiprotozoal agents inhibits tumor growth in mice, despite lacking individual efficacy.

    • Conclusions:

    • Systematic combination screening is a powerful tool for discovering novel multicomponent therapeutics.
    • This approach can reveal pathway interactions and lead to new combination drug regimens.
    • The method holds potential for exploring biological pathway connectivity.